Skip to main content

Table 2 Distribution of genes associated with antimicrobial resistance of 159 Streptococcus uberis isolated from clinical mastitis according to clinical outcomes recorded during the follow-up period

From: Whole-genome sequencing reveals high genetic diversity of Streptococcus uberis isolated from cows with mastitis

Resistance factor

Product

Antibiotic class

Mortality (% of cows infected by positive strains)

Bacteriological cure

Clinical cure

Loss of mammary quarter function.

Reoccurrence of CM

Total of positive strains

Dead

Alive

No

Yes

No

Yes

No

Yes

No

Yes

n

%

n

%

n

%

n

%

n

%

n

%

n

%

n

%

n

%

n

%

rlmA(II)

23 S rRNA (guanine(748)-N(1))-methyltransferase

Macrolides, Lincosamides

31

19

28

81

88

55

71

45

20

13

139

87

142

89

17

11

121

76

38

24

159

rpoB

DNA-directed RNA polymerase beta subunit

Rifamycins, Peptide antibiotics

31

19

128

81

88

55

71

45

20

13

139

87

142

89

17

11

121

76

38

24

159

rpoC

DNA-directed RNA polymerase beta’ subunit

Myxopyronins Corallopyronins, Peptide antibiotics

31

19

128

81

88

55

71

45

20

13

139

87

142

89

17

11

121

76

38

24

159

S10p

SSU ribosomal protein S10p

Tetracyclines, Glycylcyclines

30

19

128

81

87

55

71

45

20

13

138

87

141

89

17

11

120

76

38

24

158

alr

Alanine racemase

Cycloserine

31

20

126

80

86

55

71

45

20

13

137

87

140

89

17

11

119

76

38

24

157

EF-G

Translation elongation factor G

Fusidic acid

31

20

126

80

87

55

70

45

20

13

137

87

140

89

17

11

119

76

38

24

157

S12p

SSU ribosomal protein S12p

Aminoglycosides

31

20

126

80

87

55

70

45

20

13

137

87

140

89

17

11

119

76

38

24

157

pgsA

CDP-diacylglycerol–glycerol-3-phosphate 3-phosphatidyltransferase

Peptide antibiotics (daptomycin)

28

18

127

82

85

55

70

45

20

13

135

87

138

89

17

11

121

78

34

22

155

fabK

Enoyl-[acyl-carrier-protein] reductase [FMN, NADH]

Triclosan

30

19

124

81

84

55

70

45

20

13

134

87

138

90

16

10

116

75

38

25

154

kasA

3-oxoacyl-[acyl-carrier-protein] synthase, KASII

Isoniazid, Triclosan

30

19

124

81

84

55

70

45

20

13

134

87

138

90

16

10

116

75

38

25

154

D

Lincosamide nucleotidyltransferase = > Lnu(D)

Lincosamides

30

20

122

80

83

55

69

45

20

13

132

87

135

89

17

11

114

75

38

25

152

liaF

Membrane protein LiaF(VraT), specific inhibitor of LiaRS(VraRS) signaling pathway

Peptide antibiotics (daptomycin)

30

20

121

80

84

56

67

44

20

13

131

87

134

89

17

11

113

75

38

25

151

LiaR

Cell envelope stress response system LiaFSR, response regulator LiaR(VraR)

Peptide antibiotics (daptomycin)

30

20

121

80

84

56

67

44

20

13

131

87

134

89

17

11

113

75

38

25

151

LiaS

Cell envelope stress response system LiaFSR, sensor histidine kinase LiaS(VraS)

Peptide antibiotics (daptomycin)

30

20

121

80

84

56

67

44

20

13

131

87

134

89

17

11

113

75

38

25

151

murA

UDP-N-acetylglucosamine 1-carboxyvinyltransferase

Fosfomycin

30

20

121

80

84

56

67

44

20

13

131

87

134

89

17

11

113

75

38

25

151

gidB

16 S rRNA (guanine(527)-N(7))-methyltransferase

Aminoglycosides

29

19

121

81

83

55

67

45

20

13

130

87

133

89

17

11

112

75

38

25

150

GdpD

Glycerophosphoryl diester phosphodiesterase

Peptide antibiotics (daptomycin)

30

20

119

80

83

56

66

44

20

13

129

87

132

89

17

11

111

74

38

26

149

folP

Dihydropteroate synthase

Sulfonamides

30

20

117

80

84

57

63

43

20

14

127

86

131

89

16

11

109

74

38

26

147

ddl

D-alanine–D-alanine ligase

Cycloserine

29

20

117

80

81

55

65

45

20

14

126

86

129

88

17

12

108

74

38

26

146

Iso-tRNA

Isoleucyl-tRNA synthetase

Mupirocin

30

21

116

79

83

57

63

43

20

14

126

86

130

89

16

11

109

75

37

25

146

folA, Dfr

Dihydrofolate reductase

Diaminopyrimidines

29

20

115

80

81

56

63

44

20

14

124

86

128

89

16

11

107

74

37

26

144

gyrB

DNA gyrase subunit B

Novobiocin

29

20

115

80

80

56

64

44

20

14

124

86

127

88

17

12

106

74

38

26

144

gyrA

DNA gyrase subunit A

Ciprofloxacin

30

21

113

79

80

56

63

44

20

14

123

86

127

89

16

11

106

74

37

26

143

EF-Tu

Translation elongation factor Tu

Elfamycins

29

21

112

79

77

55

64

45

20

14

121

86

127

90

14

10

105

74

36

26

141

tetM

Tetracycline resistance, ribosomal protection type = > Tet(M)

Tetracyclines

6

13

42

88

20

42

28

58

6

13

42

88

43

90

5

10

39

81

9

19

48

parC

DNA topoisomerase IV subunit A

Ciprofloxacin

0

00

7

100

4

57

3

43

2

29

5

71

6

86

1

14

7

100

0

00

7

ant (6)-I

Aminoglycoside 6-nucleotidyltransferase

Aminoglycosides

1

25

3

75

1

25

3

75

0

00

4

100

4

100

0

00

4

100

0

00

4

bceR

Two-component response regulator BceR

Peptide antibiotics (bacitracin)

1

50

1

50

1

50

1

50

0

00

2

100

2

100

0

00

1

50

1

50

2

lsa(E)

ABC-F type ribosomal protection protein

Lincosamides

0

00

1

100

0

00

1

100

0

00

1

100

1

100

0

00

1

100

0

00

1